226 related articles for article (PubMed ID: 12642936)
1. [Effect of hormonal changes in women on hemostasis].
Malý J; Dulícek P
Vnitr Lek; 2002 Dec; 48(12):1169-73. PubMed ID: 12642936
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
3. [Contraceptive agents and risk of thrombosis].
Maurer-Major E; Keller PJ
Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
[TBL] [Abstract][Full Text] [Related]
4. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
Bounameaux H; de Moerloose P; Campana A
Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
[TBL] [Abstract][Full Text] [Related]
5. [Pregnancy, contraception and HRT and venous thromboembolism].
Conard J; Gompel A
Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
[TBL] [Abstract][Full Text] [Related]
6. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
Waselenko JK; Nace MC; Alving B
Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
[TBL] [Abstract][Full Text] [Related]
7. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
Tanis BC; Rosendaal FR
Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
[TBL] [Abstract][Full Text] [Related]
9. Exogenous sex hormones and thrombophilia.
Walker ID
Obstet Gynecol Clin North Am; 2006 Sep; 33(3):467-79, x. PubMed ID: 16962922
[TBL] [Abstract][Full Text] [Related]
10. Oral contraception and thrombophilia.
Blickstein D; Blickstein I
Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis.
Saadatnia M; Tajmirriahi M
Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives.
Martinelli I; Taioli E; Battaglioli T; Podda GM; Passamonti SM; Pedotti P; Mannucci PM
Arch Intern Med; 2003 Dec 8-22; 163(22):2771-4. PubMed ID: 14662632
[TBL] [Abstract][Full Text] [Related]
14. Hormones and pregnancy: thromboembolic risks for women.
Kujovich JL
Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
[TBL] [Abstract][Full Text] [Related]
15. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives, hormone replacement therapy and thrombosis.
Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
Thromb Haemost; 2001 Jul; 86(1):112-23. PubMed ID: 11486996
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in women taking hormonal contraceptives.
Blanco-Molina A; Monreal M
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
[TBL] [Abstract][Full Text] [Related]
19. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
20. [Hormone therapy and cardiovascular risk].
Wütschert R; Cirafici P
Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
